OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, published by Mary Ann Liebert, Inc., is a leading peer-reviewed journal dedicated to the field of integrative biology, encompassing Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine. With an ISSN of 1536-2310 and E-ISSN of 1557-8100, this esteemed journal stands out with its commitment to advancing scientific knowledge and research within its scope, particularly effective from its inception in 2002 through to 2024. The journal holds a commendable position in various Scopus ranks, notably achieving a Q2 quartile in Biotechnology and Medicine (miscellaneous), and continues to exemplify rigorous scholarship with an impactful focus on cross-disciplinary integration. Although not an open-access publication, OMICS ensures that its readership has access to significant findings that shape contemporary biological discourse. Researchers, professionals, and students alike are encouraged to contribute to and explore this journal, as it not only advances knowledge but also fosters collaboration among diverse scientific communities.

Genome Research, published by Cold Spring Harbor Laboratory Press, stands as a premier journal in the field of genetics, featuring rigorous peer-reviewed research that explores the complexities of genome organization and function. With an impressive Q1 ranking in both Genetics and Clinical Genetics according to the 2023 category quartiles, this journal effectively bridges the gap between fundamental genetic science and its clinical applications. Its significance is further highlighted by its Scopus rankings, where it ranks #6 out of 99 in Clinical Genetics and #27 out of 347 in Biochemistry, Genetics, and Molecular Biology, showcasing its broad influence and access to cutting-edge discoveries. Researchers and professionals can look forward to a diverse array of articles that cover genomic technologies, bioinformatics, and translational genomics. Although not currently open access, the wealth of information available in each issue makes it an invaluable resource for anyone engaged in genetic research and applications.

International Journal of Genomics is a pivotal open-access publication under the esteemed HINDAWI LTD, dedicated to advancing the fields of genomics, biochemistry, genetics, and molecular biology. Established in 2013, this journal aims to disseminate innovative research findings and foster scholarly dialogue among researchers, professionals, and students alike. With a robust Impact Factor reflective of its commitment to quality, the journal has achieved a Q3 ranking in Biochemistry, Genetics, and Molecular Biology, as well as notable placements in Pharmaceutical Science, indicating its broad relevance and influence in these interconnected fields. The journal is indexed in esteemed databases, ensuring high visibility and accessibility for published works. As an open-access journal, it prioritizes the sharing of knowledge across borders, facilitating greater collaboration and advancement in genomic research globally. Join the academic community in exploring the vast potential of genomics through the International Journal of Genomics, based in Egypt, and reaching audiences worldwide from its London office.

The Journal of Gene Medicine, published by Wiley, stands as a pivotal resource in the field of gene therapy and molecular medicine, with a rich history of dissemination of impactful research since its inception in 1998. With an ISSN of 1099-498X and an E-ISSN of 1521-2254, this esteemed journal plays a crucial role in advancing our understanding of genetics and drug discovery, reflected in its impressive 2023 Scopus rankings where it holds a Q2 classification in Drug Discovery and Q3 in several genetics-related categories. The journal aims to facilitate the exchange of high-quality research findings that bridge the gap between laboratory and clinical applications, making it an essential platform for researchers, academics, and healthcare professionals committed to the forefront of genetic innovation. Although it does not currently offer open access options, its reputation for rigorous peer review ensures that all published work meets the highest academic standards, providing a reliable reference for scientific inquiry in the United States and beyond. As the field rapidly evolves, the Journal of Gene Medicine remains at the helm, guiding future discoveries with its influential publications and comprehensive insights.

Genes is a leading open-access journal published by MDPI that focuses on advancing the field of genetics and genomics. Established in 2010 and based in Basel, Switzerland, this journal has made significant strides in promoting innovative research in both clinical genetics and molecular biology. With an impact factor reflecting its relevance and quality, Genes has been classified in the Q2 quartile for Genetics and the Q3 quartile for clinical Genetics as of 2023. The journal provides an accessible platform for researchers, professionals, and students to disseminate their findings and explore emerging trends across the genetics landscape. Accessible online since its inception, Genes allows for continuous engagement and collaboration within the scientific community, fostering a deeper understanding of genetic mechanisms and their implications in health and disease.

G3-Genes Genomes Genetics is a prominent open access journal published by Oxford University Press, Inc., dedicated to advancing the field of genetics and genomics. Since its inception in 2011, the journal has become a vital resource for researchers, professionals, and students, featuring high-quality, peer-reviewed articles that cover a broad spectrum of topics within genetics, including clinical genetics and molecular biology. With an impressive standing reflected in its 2023 Scopus rankings, which positions it in the Q2 category for Genetics (Clinical) and Q1 for Medicine (Miscellaneous), G3 remains at the forefront of scholarly communication in these disciplines. The journal's commitment to open access ensures that cutting-edge research is accessible to a global audience, stimulating collaboration and innovation in the field. For those eager to explore the latest in genetic research, G3 serves as an indispensable platform, inviting contributions that push the boundaries of scientific understanding.

CURRENT OPINION IN GENETICS & DEVELOPMENT is a prestigious journal published by CURRENT BIOLOGY LTD that offers an insightful platform for the latest developments and emerging trends in the fields of genetics and developmental biology. Established in 1991 and set to continue until at least 2024, this journal achieves notable recognition in the academic community with a Q1 classification in both its major categories as of 2023. With a Scopus rank placing it within the top quartile for both genetics and developmental biology, it serves as an essential resource for researchers, professionals, and students seeking to enhance their understanding of genetic mechanisms and developmental processes. While currently not an open-access journal, readers can explore the collection of high-quality articles that contribute to shaping contemporary scientific discourse and fostering innovation within these dynamic fields. For those dedicated to advancing their research and knowledge, CURRENT OPINION IN GENETICS & DEVELOPMENT stands as a vital and influential academic publication.

Open Biology is a prestigious, interdisciplinary journal published by the Royal Society that has been paving the way in the fields of Biochemistry, Genetics and Molecular Biology, Immunology, and Neuroscience since its inception in 2011. Catering to a global audience of researchers, professionals, and students, Open Biology operates under an open access model, facilitating the unrestricted dissemination of high-quality research findings. With a current impact factor that positions its categories in the top quartile (Q1) and impressive Scopus rankings—evidencing its influence and reach—this journal serves as a vital platform for innovators and scientific inquiries aimed at advancing our understanding of life sciences. The journal's commitment to publishing cutting-edge research makes it an essential resource for those at the forefront of scientific exploration.

NAR Cancer, published by Oxford University Press, is a pioneering open access journal established to advance the rapidly evolving field of cancer research. Since its inception in 2019, this journal has gained substantial recognition, achieving a prestigious Q1 ranking in both Cancer Research and Oncology categories as of 2023. With a focused objective to disseminate high-quality research, reviews, and insights into innovative cancer treatments and diagnostics, NAR Cancer serves as an essential platform for researchers, healthcare professionals, and students alike. The journal is accessible for all since it became open access in 2020, ensuring a global reach and impact. Positioned in the competitive landscape of oncology, with impressive Scopus rankings, it offers a unique opportunity for contributors to share their work with an engaged and interdisciplinary audience. With a commitment to excellence, NAR Cancer is dedicated to driving forward the understanding and management of cancer worldwide.

Cell Systems is an esteemed journal published by CELL PRESS, dedicated to advancing the field of systems biology and its applications in cell biology, histology, and pathology. Since its inception in 2015, it has quickly ascended to a prominent position within the academic community, currently holding a Q1 ranking across multiple categories including Cell Biology, Histology, and Pathology and Forensic Medicine for 2023. With an impressive Scopus ranking—third in Medicine: Pathology and Forensic Medicine, and similarly high standing in Histology—it serves as a key resource for researchers and professionals aiming to explore and disseminate cutting-edge research findings. The journal provides an open-access platform, making it an accessible source of knowledge for students and scholars alike, fostering collaboration and innovation within the dynamic landscape of cellular research. With a commitment to high-quality and impactful publications, Cell Systems plays a pivotal role in shaping the future of biological sciences.